Solid-phase synthesis of cyclic RGD-furanoid sugar amino acid peptides as integrin inhibitors

Bioorganic and Medicinal Chemistry Letters

Volumn 13, Issue 3, 2003, Pages 331-334

  Van Well, Renate M ^a   Overkleeft, Herman S ^a   Van Der Marel, Gijsbert A ^a   Bruss, Dan ^b   Thibault, Gaétan ^c   De Groot, Phillip G ^d   Van Boom, Jacques H ^a   Overhand, Mark ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b Central College   (United States)

^c CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA5 INTEGRIN; AMINO ACID DERIVATIVE; ARGINYLGLYCYLASPARTIC ACID; BETA3 INTEGRIN; INTEGRIN RECEPTOR; RECEPTOR BLOCKING AGENT; RECEPTOR PROTEIN; RECEPTOR SUBTYPE; TETRAPEPTIDE;

ARTICLE; ASSAY; BLOOD CLOTTING; CONSENSUS SEQUENCE; CYCLIZATION; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IC 50; PROTEIN ASSEMBLY; PROTEIN DEGRADATION; RECEPTOR AFFINITY; SOLID; THROMBOCYTE;

BINDING, COMPETITIVE; BLOOD COAGULATION; BLOOD PLATELETS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLIZATION; HUMANS; INDICATORS AND REAGENTS; INTEGRIN ALPHAVBETA3; INTEGRINS; OLIGOPEPTIDES; PLATELET AGGREGATION; PLATELET MEMBRANE GLYCOPROTEIN IIB; SUGAR ACIDS;

EID: 0037325514     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(02)01022-3     Document Type: Article

References (33)

1. Haubner R., Finsinger D., Kessler H. Angew. Chem., Int. Ed. Engl. 36:1997;1375.
2. Ojima I., Chakravarty S., Dong Q. Bioorg. Med. Chem. 3:1995;337.
3. Pfaff M., Tangemann K., Müller B., Gurrath M., Müller G., Kessler H., Timpl R., Engel J. J. Biol. Chem. 269:1994;20233.
4. Pierschbacher M.D., Ruoslathi E. Nature. 309:1984;30.
5. (a) Giannis A., Kolter T. Angew. Chem., Int. Ed. Engl. 32:1993;1244.
6. (b) Bogdanowich-Knipp S.J., Chakrabarti S., Williams T.D., Dillman R.K., Siahaan T.J. J. Peptide Res. 53:1999;530.
7. (a) Samanen J., Ali F., Romoff T., Calvo R., Sorensen E., Vasko J., Storer B., Berry D., Bennett D., Strohsacker M., Powers D., Stadel J., Nichols A. J. Med. Chem. 34:1991;3114.
8. (b) Jackson S., DeGrado W., Dwivedi A., Parthasarthy A., Higley A., Krywko J., Rockwell A., Markwalder J., Wells G., Wexler R., Mousa S., Harlow R. J. Am. Chem. Soc. 116:1994;3220.
9. (c) Jonczyk, A.; Hölzemann, G.; Goodman, S. L.; Kessler, H.; Haubner, R.; Wermuth, J. (Merck), DE-A 4415 310-A1, 1994.
10. (a) Fuchs E.-F., Lehmann J. Carbohyd. Res. 49:1976;267.
11. (b) Wessel H.P., Mitchell C.M., Lobato C.M., Schmid G. Angew. Chem., Int. Ed. Engl. 34:1995;2712.
12. (c) Suhara Y., Hildreth J.E.K., Ichikawa Y. Tetrahedron Lett. 37:1996;1575.
13. (d) Timmers C.M., Turner J.J., Ward C.M., van der Marel G.A., Kouwijzer M.L.C.E., Grootenhuis P.D.J., van Boom J.H. Chem. Eur. J. 3:1997;920.
14. (e) Szabo L., Smith B.L., McReynolds K.D., Parrill A.L., Morris E.R., Gervay J. J. Org. Chem. 63:1998;1074.
15. (f) Long D.D., Hungerford N.L., Smith M.D., Brittain D.E.A., Marquess D.G., Claridge T.D.W., Fleet G.W.J. Tetrahedron Lett. 40:1999;2195.
16. (g) Locardi E., Stöckle M., Gruner S., Kessler H. J. Am. Chem. Soc. 123:2001;8189.
17. (a) von Roedern E.G., Kessler H. Angew. Chem., Int. Ed. Engl. 33:1994;687.
18. (b) Smith A.B. III, Sasho S., Barwis B.A., Sprengeler P., Barbosa J., Hirschmann R., Cooperman B.S. Bioorg. Med. Chem. Lett. 8:1998;3133.
19. (c) Overkleeft H.S., Verhelst S.H.L., Pieterman E., Meeuwenoord N.J., Overhand M., Cohen L.H., van der Marel G.A., van Boom J.H. Tetrahedron Lett. 40:1999;4130.
20. (d) Chakraborty T.K., Ghosh S., Jayaprakash S., Sharma J.A.R.P., Ravikanth V., Diwan P.V., Nagaraj R., Kunwar A.C. J. Org. Chem. 65:2000;7710.
21. (e) Aguilera B., Siegal G., Overkleeft H.S., Meeuwenoord N.J., Rutjes F.P.J.T., van Hest J.C.M., Schoemaker H.E., van der Marel G.A., van Boom J.H., Overhand M. Eur. J. Org. Chem. 2001;1541.
22. Lohof E., Planker E., Mang C., Burkhart F., Dechantsreiter M.A., Haubner R., Wester H., Schwaiger M., Hölzemann G., Goodman S.L., Kessler H. Angew. Chem. Int. Ed. 39:2000;2761.
23. van Well R.M., Overkleeft H.S., Overhand M., Carstenen E.V., van der Marel G.A., van Boom J.H. Tetrahedron Lett. 41:2000;9331.
24. McDevitt J.P., Lansbury P.T. Jr. J. Am. Chem. Soc. 118:1996;3818.
25. 2O/2.5% TIS.
26. We discovered that the use of a carbodiimide in combination with HOBT as reported in literature is not optimal for linking the first amino acid to the oxime resin. The effect of different activating agents on the yield was determined by cleaving the linear precursors 8 with an excess of n-propylamine and analysis of the resulting mixtures with LCMS. We found that the use of BOP/DIPEA gave the best results.
27. Dangles O., Guibé F., Balvoine G., Lavielle S., Marquet A. J. Org. Chem. 52:1987;4984.
28. Nishino N., Xu M., Mihara H., Fujimoto T., Ueno Y., Kumagai H. Tetrahedron Lett. 33:1992;1479.
29. The sequence starting with arginine was omitted as the repetitive acidic Boc cleavage may cause partial loss of the Mtr group.
30. Thibault G., Tardif P., Lapalme G. J. Pharmacol. Exp. Ther. 296:2001;690.
31. Zucker M.B. Meth. Enzymol. 169:1988;117.
32. rGDW (r stands for D-Arg) was kindly provided by Dr. J. Bouchaudon, Rhone-Poulenc-Rorer, Chemistry Department, Centre de recherches de Vitry, France.
33. Hantgan R.R., Endenburg S.C., Cavero I., Marguerie G., Uzan A., Sixma J.J., de Groot P.G. Thrombosis Haemostasis. 68:1992;694.